BackChromocell Therapeutics Overview

Chromocell Therapeutics Goodwill

Chromocell Therapeutics's goodwill is $25M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$24.68M

Peer average

Loading

Chromocell Therapeutics Goodwill History

Loading

Chromocell Therapeutics vs. peers: Goodwill Comparison

Loading

Chromocell Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chromocell Therapeutics (CHRO) FAQ

Chromocell Therapeutics's goodwill stands at $25M as of March 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Chromocell Therapeutics reported $25M in goodwill versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Chromocell Therapeutics's goodwill evolved across reporting periods, while the comparison chart places CHRO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.